Report copyright - ANNEX I SUMMARY OF PRODUCT CHARACTERISTICSec.europa.eu/.../2016/20160715135200/anx_135200_en.pdf · thalassaemia syndromes aged 10 years and older. 4.2 Posology and method of administration
Please pass captcha verification before submit form